Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.49K Hold
18
– – ﹤0.01% 2086
2026
Q1
$5.21K Hold
18
– – ﹤0.01% 2153
2025
Q4
$4.59K Hold
18
– – ﹤0.01% 2164
2025
Q3
$5.82K Sell
18
-165
-90% -$51.6K ﹤0.01% 2108
2025
Q2
$53.9K Buy
183
+20
+12% +$5.53K ﹤0.01% 1531
2025
Q1
$43.4K Buy
163
+121
+288% +$33.8K ﹤0.01% 1562
2024
Q4
$10.6K Hold
42
– – ﹤0.01% 2032
2024
Q3
$9.25K Buy
+42
New +$8.14K ﹤0.01% 1867
2020
Q1
– Sell
-62
Closed -$8K – 2520
2019
Q4
$8K Hold
62
– – ﹤0.01% 2045
2019
Q3
$8K Hold
62
– – ﹤0.01% 1960
2019
Q2
$9K Sell
62
-1
-2% -$150 ﹤0.01% 1932
2019
Q1
$9K Sell
63
-12
-16% -$1.93K ﹤0.01% 1865
2018
Q4
$12K Hold
75
– – ﹤0.01% 1720
2018
Q3
$14K Buy
+75
New +$13.7K ﹤0.01% 1722
2017
Q3
– Sell
-17
Closed -$2K – 2123
2017
Q2
$2K Buy
17
+5
+42% +$655 ﹤0.01% 1921
2017
Q1
$1K Sell
12
-6
-33% -$856 ﹤0.01% 1976
2016
Q4
$2K Sell
18
-13
-42% -$1.76K ﹤0.01% 1850
2016
Q3
$3K Sell
31
-6,405
-100% -$778K ﹤0.01% 1691
2016
Q2
$730K Buy
6,436
+510
+9% +$54.8K 0.11% 184
2016
Q1
$625K Buy
+5,926
New +$568K 0.1% 204

Other funds holding FFIV

Geneos Wealth Management's FFIV Position: Q2 2026 in Review

Geneos Wealth Management held its F5 (FFIV) position steady in Q2 2026 at 18 shares worth $7.49K. The position accounts for ﹤0.01% of the portfolio, ranked #2086.

Geneos Wealth Management first reported a position in FFIV in Q1 2016 and has held it in 20 quarters since. The position peaked at $730K in Q2 2016. 833 funds tracked by Wall St. Rank hold FFIV as of Q2 2026.

  • Geneos Wealth Management held 18 shares of F5 worth $7.49K as of Q2 2026.
  • Geneos Wealth Management left its F5 share count unchanged in Q2 2026.
  • F5 made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2086 holding.
  • Geneos Wealth Management first reported a position in F5 in Q1 2016 and has held it in 20 quarters since.
  • Geneos Wealth Management's F5 position peaked at $730K in Q2 2016.
  • 833 funds tracked by Wall St. Rank held F5 as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.